Ozempic 0.5 mg is the first therapeutic dose of semaglutide (a GLP-1 receptor agonist) used for:
• Type 2 diabetes management
• Weight loss (off-label use)
This is typically the dose patients move to after completing 4 weeks on the starter dose of 0.25 mg, once the body has adjusted to the medication.
⸻
🔹 Ozempic 0.5 mg – Quick Facts
• Generic name: Semaglutide
• Form: Injectable pen (subcutaneous)
• Frequency: Once weekly
• Dose schedule:
• Week 1–4: 0.25 mg
• Week 5 onward: 0.5 mg
• May increase to 1 mg or 2 mg if needed
